Abstract
<jats:p>Marine biotechnology in pharmaceutical and food industries is a growing sector supported by expanding reach and financial resources worldwide. This study evaluates 620 publications and 29 projects, identifying the most promising technologies and business trends to advance materials development and improve performance. Omics, drug evaluation, and bioinformatics technologies are driving medical research and are considered essential tools to develop novel materials and candidate organisms for commercial applications. Techniques to optimize living conditions, harvesting, and purification methods, combined with recombinant technologies, are important to maximize commercial and industrial use, particularly in food and nutraceutical programs. Growth in this sector has been driven by increasing consumer demand for healthy ingredients that provide sustained health benefits, along with less stringent regulations compared to pharmaceutical products. Although this review has several limitations—particularly the author’s subjectivity in classifying publications and an imperfect selection of projects analyzed—it offers insights into trends most relevant in Europe. It does not provide a fully quantitative assessment of the current literature in drug and food applications, but it highlights the development of basic research and its implementation during the period. As such, promoting evidence-based strategy creation is the primary recommendation for overcoming barriers that limit seafood commercialization.</jats:p>